FR2315296B1 - - Google Patents

Info

Publication number
FR2315296B1
FR2315296B1 FR7618949A FR7618949A FR2315296B1 FR 2315296 B1 FR2315296 B1 FR 2315296B1 FR 7618949 A FR7618949 A FR 7618949A FR 7618949 A FR7618949 A FR 7618949A FR 2315296 B1 FR2315296 B1 FR 2315296B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7618949A
Other languages
French (fr)
Other versions
FR2315296A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SARATH
Original Assignee
SARATH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB26989/75A external-priority patent/GB1523803A/en
Application filed by SARATH filed Critical SARATH
Publication of FR2315296A1 publication Critical patent/FR2315296A1/fr
Application granted granted Critical
Publication of FR2315296B1 publication Critical patent/FR2315296B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
FR7618949A 1975-06-25 1976-06-22 Nouveaux 16-ethers de derives d'acide fusidique, utiles notamment comme antimicrobiens, et leur procede de preparation Granted FR2315296A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB26989/75A GB1523803A (en) 1975-06-25 1975-06-25 16-ethers of fusidic acid derivatives
GB4622975 1975-11-07

Publications (2)

Publication Number Publication Date
FR2315296A1 FR2315296A1 (fr) 1977-01-21
FR2315296B1 true FR2315296B1 (da) 1980-11-07

Family

ID=26258548

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7618949A Granted FR2315296A1 (fr) 1975-06-25 1976-06-22 Nouveaux 16-ethers de derives d'acide fusidique, utiles notamment comme antimicrobiens, et leur procede de preparation

Country Status (18)

Country Link
JP (1) JPS523051A (da)
AT (1) AT345979B (da)
AU (1) AU500027B2 (da)
CA (1) CA1064906A (da)
DE (1) DE2628360C2 (da)
DK (1) DK143905C (da)
ES (1) ES449257A1 (da)
FI (1) FI55852C (da)
FR (1) FR2315296A1 (da)
GR (1) GR60362B (da)
IE (1) IE43478B1 (da)
IT (1) IT1062245B (da)
LU (1) LU75239A1 (da)
NL (1) NL7606983A (da)
NZ (1) NZ181107A (da)
PT (1) PT65261A (da)
SE (1) SE7607322L (da)
SU (1) SU799670A3 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581335A (en) * 1976-07-05 1980-12-10 Leo Pharm Prod Ltd 16-s-acyl derivatives of fusidic acid
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
CA2062792C (en) * 1989-07-07 2006-03-21 Fernard Labrie Treatment of androgen-related diseases
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)

Also Published As

Publication number Publication date
LU75239A1 (da) 1977-03-16
SE7607322L (sv) 1976-12-26
FI55852C (fi) 1979-10-10
IT1062245B (it) 1983-09-20
DK285776A (da) 1976-12-26
JPS6350360B2 (da) 1988-10-07
ES449257A1 (es) 1977-12-16
IE43478L (en) 1976-12-25
CA1064906A (en) 1979-10-23
JPS523051A (en) 1977-01-11
AU1525076A (en) 1978-01-05
PT65261A (en) 1976-07-01
FI761863A (da) 1976-12-26
AU500027B2 (en) 1979-05-10
DK143905C (da) 1982-04-19
FI55852B (fi) 1979-06-29
SU799670A3 (ru) 1981-01-23
NZ181107A (en) 1978-11-13
DK143905B (da) 1981-10-26
PT65261B (da) 1977-12-07
GR60362B (en) 1978-05-19
NL7606983A (nl) 1976-12-28
ATA438776A (de) 1978-02-15
AT345979B (de) 1978-10-10
FR2315296A1 (fr) 1977-01-21
IE43478B1 (en) 1981-03-11
DE2628360A1 (de) 1977-01-13
DE2628360C2 (de) 1986-11-06

Similar Documents

Publication Publication Date Title
JPS5271588U (da)
JPS5263391U (da)
BG22245A1 (da)
BG22223A1 (da)
BG22558A1 (da)
BG22616A1 (da)
BG22694A1 (da)
BG22902A1 (da)
CH536275A4 (da)
CH588681A5 (da)
CH589383A5 (da)
CH590459A5 (da)
CH591438A5 (da)
CH592890A5 (da)
CH594132A5 (da)
CH595263A5 (da)
CH595435A5 (da)
CH595562A5 (da)
CH595961A5 (da)
CH596282A5 (da)
CH596588A5 (da)
CH598236A5 (da)
CH598286A5 (da)
CH598304A5 (da)
CH598782A5 (da)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse